Synthego was founded in 2012 by Alex Pesch, Michael Dabrowski, and Paul Dabrowski. When asked about a potential IPO, CEO Dabrowski said that while "We think we can basically be ready for that anytime... From a publicity standpoint, from a people and teams standpoint, a financial capital needs standpoint, now we’ve decided to stay private." These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO.
Synthego is a genome engineering company leveraging machine learning, automation, and gene editing to build platforms at scale. The company is a major developer of the tools which are used in CRISPR therapies, citing more than 1,000 peer-reviewed studies that have used its technology in at least one step. The company has raised more than $450 million in venture capital funding from investors including Perceptive Advisors LLC, SoftBank Vision Fund 2, Moore Strategic Ventures, Declaration Partners, Laurion Capital Management, and Logos Capital. Synthego did not release valuation information after a $200 million equity round in early 2022, but it is estimated at between $800 million and $1.2 billion.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/17/2022 | Series E | $144.17MM | $xx.xx | $1.3B | Chimera Abu Dhabi, Declaration Partners, Gigafund, Laurion Capital Management, Logos Capital, Moore Strategic Ventures, Perceptive Advisors, Ra Capital Management, Softbank, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
13,371,000
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Chimera Abu Dhabi, Declaration Partners, Gigafund, Laurion Capital Management, Logos Capital, Moore Strategic Ventures, Perceptive Advisors, Ra Capital Management, Softbank, Wellington Management
|
||||||
08/26/2020 | Series D | $100MM | $xx.xx | $486.63MM | 8vc, Founders Fund, Intel Capital, Menlo Ventures, Ra Capital Management, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
18,925,988
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Founders Fund, Intel Capital, Menlo Ventures, Ra Capital Management, Wellington Management
|
||||||
10/23/2018 | Series C | $116.27MM | $xx.xx | $381.27MM | 8vc, Founders Fund, Menlo Ventures | |
Price per Share
$xx.xx
Shares Outstanding
22,005,928
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Founders Fund, Menlo Ventures
|
||||||
01/04/2017 | Series B-1 | $4.45MM | $xx.xx | $115.78MM | 8vc, Alexandria Equities, Ame Cloud Ventures, Elements Capital, Founders Fund, Menlo Ventures, Os Fund, Scifi Vc, Wi Harper Group, Zhenfund | |
Price per Share
$xx.xx
Shares Outstanding
1,942,877
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Alexandria Equities, Ame Cloud Ventures, Elements Capital, Founders Fund, Menlo Ventures, Os Fund, Scifi Vc, Wi Harper Group, Zhenfund
|
||||||
01/04/2017 | Series B | $41.88MM | $xx.xx | $115.78MM | 8vc, Alexandria Equities, Ame Cloud Ventures, Elements Capital, Founders Fund, Menlo Ventures, Os Fund, Scifi Vc, Wi Harper Group, Zhenfund | |
Price per Share
$xx.xx
Shares Outstanding
17,369,511
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
8vc, Alexandria Equities, Ame Cloud Ventures, Elements Capital, Founders Fund, Menlo Ventures, Os Fund, Scifi Vc, Wi Harper Group, Zhenfund
|
||||||
07/05/2013 | Series A | $8.3MM | $xx.xx | $33.21MM | Founders Fund, Menlo Ventures, Scifi Vc, Wi Harper Group | |
Price per Share
$xx.xx
Shares Outstanding
9,501,792
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Founders Fund, Menlo Ventures, Scifi Vc, Wi Harper Group
|